Loading…

Continuous glucose monitoring in diabetes

Moe et al discuss continuous glucose monitoring in diabetes. Continuous glucose monitors use subcutaneous sensors and include real-time monitors (RTMs) and flash monitors (FMs). In patients with type 1 diabetes, RTM use is associated with lower rates of severe hypoglycemic events (6%) compared with...

Full description

Saved in:
Bibliographic Details
Published in:Canadian family physician 2023-06, Vol.69 (6), p.406-406
Main Authors: Moe, Samantha S, Kolber, Michael R, Falk, Jamie
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Moe et al discuss continuous glucose monitoring in diabetes. Continuous glucose monitors use subcutaneous sensors and include real-time monitors (RTMs) and flash monitors (FMs). In patients with type 1 diabetes, RTM use is associated with lower rates of severe hypoglycemic events (6%) compared with SMBG use (8%), with no reported events in those with type 2 diabetes. Effects on hemoglobin A1c (HbA1c) may not be clinically meaningful. Compared with SMBG, FMs do not differ regarding rates of severe hypoglycemic events, and effects on HbA1c are inconsistent (type 1) or similar (type 2). Cost may limit use.
ISSN:0008-350X
1715-5258
DOI:10.46747/cfp.6906406